Skip to main content
. 2021 Mar 9;35(3):75–83. doi: 10.1089/apc.2020.0224

Table 3.

Factors Associated with HIV Treatment Self-Efficacy Score Among Survey Participants

Factor Univariate
Multivariate
Estimatea 95% CI p-Value Estimate 95% CI p-Value
Race
 Others −9.9 −27.8 to 8 0.2784      
 Hispanic −0.8 −18.7 to 17.1 0.9335      
 African American −4.1 −13.4 to 5.2 0.3859      
 White (reference) 0          
Age (years) 0.3 −0.1 to 0.8 0.1529      
Stable housing            
 Yes 2.7 −7.7 to 13.2 0.6070      
 No (reference) 0          
Years in school 0.3 −1.0 to 1.7 0.6356      
Depressive symptoms            
 Yes (CES-D ≥ 16)b −14.2 −21.4 to −7.1 <.0001 −12.1 −19.3 to −4.9 0.001
 No (CES-D <16) (reference) 0          
Reported drug use −5.8 −14.6 to 2.9 0.1931      
Alcohol use
 0–7 drinks/week (reference) 0          
 >7 drinks/week −5.3 −24.3 to 13.7 0.5860      
Smoking
 Never smoker (reference) 0          
 Current smoker −1.9 −10.3 to 6.5 0.6628      
 Former smoker −1.8 −9.4 to 5.8 0.6472      
Health care provider trustc 3.3 1.4 to 5.2 0.0008 2.8 0.9 to 4.7 0.0039
Number of years seeing current Provider 0.3 −0.1 to 0.6 0.1938      
Concordance between ideal and reported relationship with providers
 Yes 6.6 −1.2 to 14.4 0.0951 4.9 −2.5 to 12.4 0.1927
 No (reference) 0          
a

Estimated change in total HIV treatment self-efficacy score.

b

Depressive symptoms were assessed using the CES-D Scale.

c

Health care provider trust was measured on a scare of 1–10 (1 = not at all; 10 = completely).

CES-D, Center for Epidemiological Studies Depression; CI, confidence interval.